Dow Up 0.26% Nasdaq Down 1.07%

Trevena, Inc. (TRVN)

-NasdaqGS
5.74 0.18(3.04%) Sep 15, 3:59PM EDT
Prev Close:5.92
Open:5.95
Bid:0.01 x 100
Ask:200,000.00 x 100
1y Target Est:14.33
Beta:N/A
Next Earnings Date:N/A
Day's Range:5.65 - 6.00
52wk Range:4.07 - 9.95
Volume:51,535
Avg Vol (3m):181,336
Market Cap:151.31M
P/E (ttm):N/A
EPS (ttm):-6.49
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for TRVN

Comparison

Symbol% ChgMkt Cap
TRVNDown 3.04%151.31M
CYTK138.38M
NVS228.50B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.93
Quarterly EPS Est (Sep-14) :-0.45
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Trevena, Inc., a clinical stage biopharmaceutical company, discovers, develops, and intends to commercialize therapeutics for G protein coupled receptors. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback